GLP-1 Therapy May Offer Added Benefit in IBD Beyond Weight Loss

(MedPage Today) — LAS VEGAS — GLP-1-based therapies may offer benefits in the treatment of inflammatory bowel diseases (IBD) that extend beyond their metabolic indication, according to two poster presentations at the Crohn’s & Colitis conference. In a large…